This is what we do
Providing commercial and business development support to companies in the chemical-pharmaceutical and pharmaceutical industry that want to start, or increase, their commercial activities in the Spanish or European market.
Focused on companies whose factories are not recognized by the EU quality standards and want to have products manufactured in a GMP-European factory.
BioPharma Synergies has an R&D team that provides support in different areas.
Agents
The main target of BioPharma Synergies is to provide commercial and business development support to companies in the chemical-pharmaceutical and pharmaceutical industry that want to start, or increase, their commercial activities in the Spanish or European market. The company also provides technical and regulatory support when it is required.
Benefits for Suppliers
- To increase income and turnover through collaborative partnerships
- Excel your production demand
- Widen your market presence
- Embrace the Globalization process
- Add value to your products
- Increase brand positioning
Benefits for Customers
- BioPharma Synergies offers drug components with more competitive prices.
- Providing more security to the brand by offering products from differents countries, which minimizes the risk of having possible supply chain contingencies.
- Having a home domestic support with local representatives in foreign countries capable of solving your possible adverse circumstances.
- Covering the European market gaps to excel the sales
- Having customised service throughout the whole year
R & D
BioPharma Synergies has an R&D team that provides support in different areas. One of its functions is to develop synthesis processes for advanced intermediates and/or APIs, contracting industrial production with accredited manufacturers. On the other hand, they also assist Tech Transfer processes to adapt them to European standards.
Tech Transfers
Having your products in EU and in USA markets through Tech Transfers to BioPharma Synergies.
GENERICS +
On the selling of generics, we want our products to be differentiated from the competitors, due to this reason our team is betting for this new category of products: GENERICS + (plus).
The main goal is to add an extra value to the product that will be achieved by providing different delivery forms of the product thanks to our patent:
Orodispersible Powder in Stick Packs or Tablets.
Orodispersible Formulation Technology Platform
Developed in collaboration with the University of Barcelona
Our technology, among other benefits, has proved:
- Excellent masking of bad API taste
- Avoid the need of water intake
- Suitable for diabetics and lactose intolerant
- Simple and cost-effective manufacturing process
Technology for different dosage forms:
- Chewable tablets
- Orodispersible Powder in Stick packs
- Orodispersible tablets
Published EP-PCT:
